Polyamines in frontal cortex of patients with Down syndrome and Alzheimer disease

Neuroscience Letters

Volumn 206, Issue 2-3, 1996, Pages 193-195

  Seidl, Rainer ^a   Beninati, Simone ^b   Cairns, Nigel ^c   Singewald, Nicolas ^d   Risser, Daniele ^a   Bavan, Halina ^a   Nemethova, Maria ^a   Lubec, Gert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Alzheimer disease; Down syndrome; Frontal cortex; Human brain; Polyamines; Spermidine; Spermine

Indexed keywords

CHOLINE ACETYLTRANSFERASE; POLYAMINE; SPERMIDINE; SPERMINE;

ADULT; AGED; ALZHEIMER DISEASE; AMINO ACID BRAIN LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

EID: 0029965257     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)12451-4     Document Type: Article

References (19)

1. Beninati, S., Piacentini, M., Argento-Ceŕ, M.P., Russo-Caia, S. and Autuori, F., Biochem. Biophys. Acta, 841 (1985) 120-126.
2. Bernstein, H.G. and Muller, M., Increased immunostaining for L-ornithine decarboxylase occurs in neocortical neurons of Alzheimer's disease patients, Neurosci. Lett., 186 (1995) 123-126.
3. Bliss, T.V.P. and Collingridge, G.L., A synaptic model of memory: long-term potentiation in the hippocampus, Nature, 361 (1993) 31-39.
4. Danysz, W. and Archer, T., Glutamate, learning and dementia-selection of evidence, Amino Acids, 7 (1994) 147-163.
5. Dingledine, R. and McBain, C.J., Excitatory amino acid transmitters. In G.J. Siegel (Ed.), Basic Neurochemistry, 5th edn., Raven Press, London, 1994, pp. 367-387.
6. Epstein, C.J., Down syndrome (trisomy 21). In C.R. Sriver, A.L. Beaudet, W.S. Sly and D. Valle (Eds.), The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill, New York, 1995, pp. 749-794.
7. Fonnum, F., Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities, Biochem. J., 115 (1969) 465-472.
8. Gotti, B., Benavides, J., MacKenzie, E.T. and Scatton, B., The pharmacotherapy of focal cortical ischemia in the mouse, Brain Res., 522 (1990) 290-307.
9. Ingram, D.K., Spangler, E.L., Iijima, S., Ikari, H., Kuo, H., Greig, N.H. and London, E.D., Rodent models of memory dysfunction in Alzheimer's disease and normal aging: moving beyond the cholinergic hypothesis, Life Sci., 55 (1994) 2037-2049.
10. Marvizon, J.C. and Baudry, M., Allosteric interactions and modulator requirement for NMDA receptor function, Eur. J. Pharmacol., 269 (1994) 165-175.
11. Mirra, S.S., Heyman, A., McKeel, D., Sumi, S.M. and Crain, B.J., The consortium to establish a registry for Alzheimer's disease (CERAD), II: standardisation of the neuropathological assessment of Alzheimer's disease, Neurology, 41 (1991) 479-486.
12. Morrison, L.D., Becker, L. and Kish, S.J., S-Adenosylmethionine decarboxylase in human brain: regional distribution and influence of aging, Brain Res. Dev. Brain Res., 73 (1993) 237-241.
13. Paschen, W., Polyamine metabolism in different pathological states of the brain, Mol. Chem. Neuropathol., 16 (1992) 241-271.
14. Seiler, N., ????, Methods Biochem. Anal., 18 (1970) 259-265.
15. Shaw, G.G., The polyamines in the central nervous system, Biochem. Pharmacol., 28 (1979) 1-6.
16. Siddiqui, F. and Iqbal, Z., Regulation of N-methyl-D-aspartate receptor-mediated calcium transport and norepinephrine release in rat hippocampus synaptosomes by polyamines, Neurochem. Res., 19 (1994) 1421-1429.
17. Singewald, N., Guo, L. and Philippu, A., In vivo release patterns and cardiovascular properties of inhibitory and excitatory amino acids in the hypothalamus, Amino Acids, 8 (1995) 47-58.
18. Tierney, M.C., Fisher, R.H., Lewis, A.J., Torzitto, M.L., Snow, W.G., Reid, D.W., Nieuwstraten, P., Van Rooijen, L.A.A., Derks, H.J.G.M., Van Wijk, R. and Bischop, A., The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease, Neurology, 38 (1988) 359-364.
19. Wisniewski, K.E., Wisniewski, H.M. and Wen, G.Y., Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down syndrome, Ann. Neurol., 17 (1985) 278-282.